{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:27:16Z","timestamp":1788532036448,"version":"build-2803163510"},"reference-count":122,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,15]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Breast cancer remains the most prevalent malignancy among women worldwide, underscoring the urgent need for innovative therapeutic strategies. Stem cell\u2013based anticancer approaches have attracted substantial attention because of their ability to generate immune-related cells and selectively home to tumor sites, among which mesenchymal stem cells (MSCs) are considered particularly promising owing to their strong tumor\u2010tropic capacity and low immunogenicity. In this review, current evidence on the biological functions and therapeutic potential of MSCs and MSC-derived exosomes in breast cancer was systematically compiled and analyzed, with particular emphasis on MSC-mediated cytokine signaling, modulation of the tumor microenvironment, and the molecular cargo and functional effects of MSC-derived exosomes. The available data indicate that MSCs exert context-dependent dual effects, either promoting or inhibiting tumor growth through secretion of cytokines and activation of intercellular signaling pathways, while exosomes derived from MSCs likewise display both antitumor and protumor activities yet retain intrinsic tumor-targeting capability. Notably, compared with live MSCs, exosomes demonstrate greater stability, reduced immunogenic risk, and enhanced feasibility as therapeutic delivery vehicles, highlighting their translational potential. Accumulating evidence suggests that immune regulation and remodeling of the tumor microenvironment represent central mechanisms underlying these bidirectional effects. Collectively, MSCs and their derived exosomes constitute promising therapeutic platforms for breast cancer; however, their context-dependent regulatory properties necessitate rigorous mechanistic investigation and careful optimization prior to clinical application, and a deeper understanding of the molecular pathways through which they influence tumor progression will be essential for the development of safer and more effective stem cell\u2013based anticancer therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048829","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:01:29Z","timestamp":1778896889000},"page":"e48829","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The potential of stem cells in breast cancer therapy: A review"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3594-8276","authenticated-orcid":false,"given":"Zundong","family":"Liu","sequence":"first","affiliation":[{"name":"Stem Cell Center, Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dachun","family":"Wang","sequence":"additional","affiliation":[{"name":"Stem Cell Center, Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian Province, China"},{"name":"The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Medical School at Houston, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260904","first-page":"7","article-title":"Cancer statistics, 2022.","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"R2-20260904","doi-asserted-by":"crossref","first-page":"102223","DOI":"10.1016\/j.ctrv.2021.102223","article-title":"Precision medicine in breast cancer: from clinical trials to clinical practice.","volume":"98","author":"Crimini","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"R3-20260904","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-017-0004-3","article-title":"Controlled drug delivery vehicles for cancer treatment and their performance.","volume":"3","author":"Senapati","year":"2018","journal-title":"Signal Transduct Target Ther"},{"key":"R4-20260904","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies.","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"R5-20260904","doi-asserted-by":"crossref","first-page":"120546","DOI":"10.1016\/j.biomaterials.2020.120546","article-title":"Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment.","volume":"268","author":"Zhou","year":"2021","journal-title":"Biomaterials"},{"key":"R6-20260904","doi-asserted-by":"crossref","first-page":"119182","DOI":"10.1016\/j.biomaterials.2019.04.027","article-title":"Advances in drug delivery for post-surgical cancer treatment.","volume":"219","author":"Bu","year":"2019","journal-title":"Biomaterials"},{"key":"R7-20260904","first-page":"723","article-title":"Thymoquinone-loaded mesenchymal stem cell-derived exosome as an efficient nano-system against breast cancer cells.","volume":"25","author":"Ebrahimian","year":"2022","journal-title":"Iran J Basic Med Sci"},{"key":"R8-20260904","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/jim-2021-002194","article-title":"Exosome as a target for cancer treatment.","volume":"70","author":"Nafar","year":"2022","journal-title":"J Investig Med"},{"key":"R9-20260904","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/197452a0","article-title":"Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells.","volume":"197","author":"Becker","year":"1963","journal-title":"Nature"},{"key":"R10-20260904","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2307\/3570877","article-title":"The radiation sensitivity of normal mouse bone marrow cells, determined by quantitative marrow transplantation into irradiated mice.","volume":"13","author":"McCulloch","year":"1960","journal-title":"Radiat Res"},{"key":"R11-20260904","doi-asserted-by":"crossref","first-page":"8810813","DOI":"10.1155\/2020\/8810813","article-title":"Adipose-derived stem cells: current applications and future directions in the regeneration of multiple tissues.","volume":"2020","author":"Zhang","year":"2020","journal-title":"Stem Cells Int"},{"key":"R12-20260904","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.3390\/ijms20102523","article-title":"Regenerative capacity of adipose derived stem cells (ADSCs), comparison with mesenchymal stem cells (MSCs).","volume":"20","author":"Mazini","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R13-20260904","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.scr.2015.02.003","article-title":"Stem cell treatment of degenerative eye disease.","volume":"14","author":"Mead","year":"2015","journal-title":"Stem Cell Res"},{"key":"R14-20260904","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","article-title":"Mesenchymal stem cell perspective: cell biology to clinical progress.","volume":"4","author":"Pittenger","year":"2019","journal-title":"npj Regener Med"},{"key":"R15-20260904","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14653240310004539","article-title":"Yield of human adipose-derived adult stem cells from liposuction aspirates.","volume":"6","author":"Aust","year":"2004","journal-title":"Cytotherapy"},{"key":"R16-20260904","first-page":"1235","article-title":"Umbilical cord revisited: from Wharton\u2019s jelly myofibroblasts to mesenchymal stem cells.","volume":"28","author":"Corrao","year":"2013","journal-title":"Histol Histopathol"},{"key":"R17-20260904","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/ID.0b013e3181835b13","article-title":"Toward the identification of mesenchymal stem cells in bone marrow and peripheral blood for bone regeneration.","volume":"17","author":"Smiler","year":"2008","journal-title":"Implant Dent"},{"key":"R18-20260904","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1359\/jbmr.2003.18.4.696","article-title":"Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp.","volume":"18","author":"Shi","year":"2003","journal-title":"J Bone Miner Res"},{"key":"R19-20260904","doi-asserted-by":"crossref","first-page":"21507","DOI":"10.1038\/srep21507","article-title":"Comprehensive transcriptomic and proteomic characterization of human mesenchymal stem cells reveals source specific cellular markers.","volume":"6","author":"Billing","year":"2016","journal-title":"Sci Rep"},{"key":"R20-20260904","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/stem.3242","article-title":"Stem cell homing: from physiology to therapeutics.","volume":"38","author":"Liesveld","year":"2020","journal-title":"Stem Cells"},{"key":"R21-20260904","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression.","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res"},{"key":"R22-20260904","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13287-019-1165-5","article-title":"Stem cells: past, present, and future.","volume":"10","author":"Zakrzewski","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"R23-20260904","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nec.2006.10.004","article-title":"Human embryonic stem cells.","volume":"18","author":"Choong","year":"2007","journal-title":"Neurosurg Clin N Am"},{"key":"R24-20260904","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/15384047.2017.1385681","article-title":"Embryonic stem cell secreted factors decrease invasiveness of triple-negative breast cancer cells through regulome modulation.","volume":"19","author":"Tarasewicz","year":"2018","journal-title":"Cancer Biol Ther"},{"key":"R25-20260904","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13287-016-0360-x","article-title":"Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancer.","volume":"7","author":"He","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"R26-20260904","doi-asserted-by":"crossref","first-page":"1561119","DOI":"10.1080\/2162402X.2018.1561119","article-title":"Exosomes from GM-CSF expressing embryonic stem cells are an effective prophylactic vaccine for cancer prevention.","volume":"8","author":"Yaddanapudi","year":"2019","journal-title":"Oncoimmunology"},{"key":"R27-20260904","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.3727\/096368912X657927","article-title":"Human embryonic stem cell-derived endothelial cells as cellular delivery vehicles for treatment of metastatic breast cancer.","volume":"22","author":"Su","year":"2013","journal-title":"Cell Transplant"},{"key":"R28-20260904","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","article-title":"Pluripotent stem cell-based cell therapy-promise and challenges.","volume":"27","author":"Yamanaka","year":"2020","journal-title":"Cell Stem Cell"},{"key":"R29-20260904","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.nano.2019.102146","article-title":"Biomimetic nanovesicles made from iPS cell-derived mesenchymal stem cells for targeted therapy of triple-negative breast cancer.","volume":"24","author":"Zhao","year":"2020","journal-title":"Nanomedicine"},{"key":"R30-20260904","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41551-018-0237-7","article-title":"Towards a personalized iPSC-based vaccine.","volume":"2","author":"Goyvaerts","year":"2018","journal-title":"Nat Biomed Eng"},{"key":"R31-20260904","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.stem.2018.01.016","article-title":"Autologous iPSC-based vaccines elicit anti-tumor responses in vivo.","volume":"22","author":"Kooreman","year":"2018","journal-title":"Cell Stem Cell"},{"key":"R32-20260904","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.stemcr.2021.04.004","article-title":"Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer.","volume":"16","author":"Ouyang","year":"2021","journal-title":"Stem Cell Rep"},{"key":"R33-20260904","doi-asserted-by":"crossref","first-page":"541","DOI":"10.14348\/molcells.2021.0078","article-title":"iPSC-derived natural killer cells for cancer immunotherapy.","volume":"44","author":"Karagiannis","year":"2021","journal-title":"Mol Cells"},{"key":"R34-20260904","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.stem.2018.10.005","article-title":"Enhancing T cell receptor stability in rejuvenated iPSC-derived T cells improves their use in cancer immunotherapy.","volume":"23","author":"Minagawa","year":"2018","journal-title":"Cell Stem Cell"},{"key":"R35-20260904","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41467-020-20658-3","article-title":"A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy.","volume":"12","author":"Iriguchi","year":"2021","journal-title":"Nat Commun"},{"key":"R36-20260904","doi-asserted-by":"crossref","first-page":"104843","DOI":"10.1016\/j.phrs.2020.104843","article-title":"Adipose-derived mesenchymal stem cells and extracellular vesicles confer antitumor activity in preclinical treatment of breast cancer.","volume":"157","author":"Li","year":"2020","journal-title":"Pharmacol Res"},{"key":"R37-20260904","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/s41419-018-0949-3","article-title":"MSCs inhibit tumor progression and enhance radiosensitivity of breast cancer cells by down-regulating Stat3 signaling pathway.","volume":"9","author":"He","year":"2018","journal-title":"Cell Death Dis"},{"key":"R38-20260904","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.canlet.2008.04.032","article-title":"Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling.","volume":"269","author":"Qiao","year":"2008","journal-title":"Cancer Lett"},{"key":"R39-20260904","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.canlet.2010.04.007","article-title":"Human umbilical cord blood mesenchymal stem cell-derived extracellular matrix prohibits metastatic cancer cell MDA-MB-231 proliferation.","volume":"296","author":"Sun","year":"2010","journal-title":"Cancer Lett"},{"key":"R40-20260904","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.biocel.2017.12.013","article-title":"The inhibitory influence of adipose tissue-derived mesenchymal stem cell environment and Wnt antagonism on breast tumour cell lines.","volume":"95","author":"Visweswaran","year":"2018","journal-title":"Int J Biochem Cell Biol"},{"key":"R41-20260904","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.3390\/ijms20071656","article-title":"Conditioned medium from human mesenchymal stromal cells: towards the clinical translation.","volume":"20","author":"Sagaradze","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R42-20260904","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/mc.22178","article-title":"Mesenchymal stem cells inhibit breast cancer cell migration and invasion through secretion of tissue inhibitor of metalloproteinase-1 and -2.","volume":"54","author":"Clarke","year":"2015","journal-title":"Mol Carcinog"},{"key":"R43-20260904","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/j.1582-4934.2011.01459.x","article-title":"Human umbilical cord mesenchymal stem cells suppress breast cancer tumourigenesis through direct cell-cell contact and internalization.","volume":"16","author":"Chao","year":"2012","journal-title":"J Cell Mol Med"},{"key":"R44-20260904","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12935-021-01977-x","article-title":"Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer.","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int"},{"key":"R45-20260904","doi-asserted-by":"crossref","first-page":"e0123756","DOI":"10.1371\/journal.pone.0123756","article-title":"Human umbilical cord matrix mesenchymal stem cells suppress the growth of breast cancer by expression of tumor suppressor genes.","volume":"10","author":"Ohta","year":"2015","journal-title":"PLoS One"},{"key":"R46-20260904","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10561-019-09781-8","article-title":"An anticancer effect of umbilical cord-derived mesenchymal stem cell secretome on the breast cancer cell line.","volume":"20","author":"Mirabdollahi","year":"2019","journal-title":"Cell Tissue Bank"},{"key":"R47-20260904","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10561-021-09984-y","article-title":"Synergistic inhibitory effect of human umbilical cord matrix mesenchymal stem cells-conditioned medium and atorvastatin on MCF7 cancer cells viability and migration.","volume":"23","author":"Abolghasemi","year":"2022","journal-title":"Cell Tissue Bank"},{"key":"R48-20260904","first-page":"71","article-title":"Human umbilical cord mesenchymal stem cells alleviate interstitial fibrosis and cardiac dysfunction in a dilated cardiomyopathy rat model by inhibiting TNF\u2011\u03b1 and TGF\u2011\u03b21\/ERK1\/2 signaling pathways.","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol Med Rep"},{"key":"R49-20260904","doi-asserted-by":"crossref","first-page":"37019","DOI":"10.1038\/srep37019","article-title":"Human endometrial mesenchymal stem cells exhibit intrinsic anti-tumor properties on human epithelial ovarian cancer cells.","volume":"6","author":"Bu","year":"2016","journal-title":"Sci Rep"},{"key":"R50-20260904","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/cgt.2012.30","article-title":"Potential antitumor therapeutic strategies of human amniotic membrane and amniotic fluid-derived stem cells.","volume":"19","author":"Kang","year":"2012","journal-title":"Cancer Gene Ther"},{"key":"R51-20260904","doi-asserted-by":"crossref","first-page":"e00726","DOI":"10.1002\/mgg3.726","article-title":"The human amniotic fluid mesenchymal stem cells therapy on, SKOV3, ovarian cancer cell line.","volume":"7","author":"Gholizadeh-Ghaleh Aziz","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"R52-20260904","doi-asserted-by":"crossref","first-page":"1241323","DOI":"10.1155\/2018\/1241323","article-title":"IFN\u03b1-expressing amniotic fluid-derived mesenchymal stem cells migrate to and suppress HeLa cell-derived tumors in a mouse model.","volume":"2018","author":"Zhou","year":"2018","journal-title":"Stem Cells Int"},{"key":"R53-20260904","doi-asserted-by":"crossref","first-page":"10692","DOI":"10.18632\/oncotarget.2530","article-title":"Potential therapeutic effect of the secretome from human uterine cervical stem cells against both cancer and stromal cells compared with adipose tissue stem cells.","volume":"5","author":"Eir\u00f3","year":"2014","journal-title":"Oncotarget"},{"key":"R54-20260904","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s12015-014-9514-3","article-title":"Human Wharton\u2019s jelly stem cells, its conditioned medium and cell-free lysate inhibit the growth of human lymphoma cells.","volume":"10","author":"Lin","year":"2014","journal-title":"Stem Cell Rev Rep"},{"key":"R55-20260904","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13045-021-01208-w","article-title":"Mesenchymal stem\/stromal cells in cancer therapy.","volume":"14","author":"Lan","year":"2021","journal-title":"J Hematol Oncol"},{"key":"R56-20260904","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/jnci\/djh299","article-title":"Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.","volume":"96","author":"Studeny","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R57-20260904","first-page":"3603","article-title":"Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors.","volume":"62","author":"Studeny","year":"2002","journal-title":"Cancer Res"},{"key":"R58-20260904","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/07357900701871134","article-title":"Combination treatment of human umbilical cord matrix stem cell-based interferon-beta gene therapy and 5-fluorouracil significantly reduces growth of metastatic human breast cancer in SCID mouse lungs.","volume":"26","author":"Rachakatla","year":"2008","journal-title":"Cancer Invest"},{"key":"R59-20260904","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1158\/0008-5472.CAN-08-0160","article-title":"Neo-organoid of marrow mesenchymal stromal cells secreting interleukin-12 for breast cancer therapy.","volume":"68","author":"Eliopoulos","year":"2008","journal-title":"Cancer Res"},{"key":"R60-20260904","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.2147\/IJN.S26155","article-title":"Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy.","volume":"6","author":"Bizzarri","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"R61-20260904","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1080\/15384101.2018.1489178","article-title":"Azurin interaction with the lipid raft components ganglioside GM-1 and caveolin-1 increases membrane fluidity and sensitivity to anti-cancer drugs.","volume":"17","author":"Bernardes","year":"2018","journal-title":"Cell Cycle"},{"key":"R62-20260904","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biocel.2014.01.023","article-title":"High-throughput molecular profiling of a P-cadherin overexpressing breast cancer model reveals new targets for the anti-cancer bacterial protein azurin.","volume":"50","author":"Bernardes","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"key":"R63-20260904","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3389\/fcell.2020.00471","article-title":"Conditioned medium from azurin-expressing human mesenchymal stromal cells demonstrates antitumor activity against breast and lung cancer cell lines.","volume":"8","author":"Silva","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"R64-20260904","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ijc.31079","article-title":"Novel targets for sensitizing breast cancer cells to TRAIL-induced apoptosis with siRNA delivery.","volume":"142","author":"Thapa","year":"2018","journal-title":"Int J Cancer"},{"key":"R65-20260904","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis.","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity"},{"key":"R66-20260904","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrc.2017.28","article-title":"Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy.","volume":"17","author":"von Karstedt","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"R67-20260904","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and antitumor activity of recombinant soluble Apo2 ligand.","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J Clin Invest"},{"key":"R68-20260904","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1158\/0008-5472.CAN-08-4698","article-title":"Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer.","volume":"69","author":"Loebinger","year":"2009","journal-title":"Cancer Res"},{"key":"R69-20260904","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.7150\/thno.58779","article-title":"Preventing tumor progression to the bone by induced tumor-suppressing MSCs.","volume":"11","author":"Sun","year":"2021","journal-title":"Theranostics"},{"key":"R70-20260904","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/07853890410018934","article-title":"Adenoviruses for treatment of cancer.","volume":"37","author":"Kanerva","year":"2005","journal-title":"Ann Med"},{"key":"R71-20260904","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10549-006-9449-8","article-title":"Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma.","volume":"105","author":"Stoff-Khalili","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"R72-20260904","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13287-018-0831-3","article-title":"Dental pulp stem cells used to deliver the anticancer drug paclitaxel.","volume":"9","author":"Salehi","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"R73-20260904","doi-asserted-by":"crossref","first-page":"e0203426","DOI":"10.1371\/journal.pone.0203426","article-title":"Adipose-derived stem cell-mediated paclitaxel delivery inhibits breast cancer growth.","volume":"13","author":"Scioli","year":"2018","journal-title":"PLoS One"},{"key":"R74-20260904","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.7150\/thno.14158","article-title":"Dihydropyrimidine dehydrogenase is a prognostic marker for mesenchymal stem cell-mediated cytosine deaminase gene and 5-fluorocytosine prodrug therapy for the treatment of recurrent gliomas.","volume":"6","author":"Chung","year":"2016","journal-title":"Theranostics"},{"key":"R75-20260904","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1073\/pnas.0700052104","article-title":"A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells.","volume":"104","author":"Wang","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"R76-20260904","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/mt.2009.317","article-title":"Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice.","volume":"18","author":"Wang","year":"2010","journal-title":"Mol Ther"},{"key":"R77-20260904","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/stem.1570","article-title":"A site-specific genetic modification for induction of pluripotency and subsequent isolation of derived lung alveolar epithelial type II cells.","volume":"32","author":"Yan","year":"2014","journal-title":"Stem Cells"},{"key":"R78-20260904","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/stem.665","article-title":"Mesenchymal stem cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer.","volume":"29","author":"Dwyer","year":"2011","journal-title":"Stem Cells"},{"key":"R79-20260904","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/CM9.0000000000000720","article-title":"Micro-vesicles from mesenchymal stem cells over-expressing miR-34a inhibit transforming growth factor-\u03b21-induced epithelial-mesenchymal transition in renal tubular epithelial cells in vitro.","volume":"133","author":"He","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"R80-20260904","doi-asserted-by":"crossref","first-page":"e84256","DOI":"10.1371\/journal.pone.0084256","article-title":"Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells.","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One"},{"key":"R81-20260904","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s13402-017-0335-7","article-title":"MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR\/HIF-1\u03b1\/VEGF signaling axis in breast cancer cells.","volume":"40","author":"Pakravan","year":"2017","journal-title":"Cell Oncol (Dordr)"},{"key":"R82-20260904","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s12282-021-01218-z","article-title":"Human umbilical cord mesenchymal stem cell-derived exosomes inhibit migration and invasion of breast cancer cells via miR-21-5p\/ZNF367 pathway.","volume":"28","author":"Du","year":"2021","journal-title":"Breast Cancer"},{"key":"R83-20260904","doi-asserted-by":"crossref","first-page":"101333","DOI":"10.1016\/j.tranon.2021.101333","article-title":"Extracellular vesicles extracted from bone marrow mesenchymal stem cells carrying MicroRNA-342-3p inhibit the INHBA\/IL13R\u03b12 axis to suppress the growth and metastasis of breast cancer.","volume":"18","author":"Liu","year":"2022","journal-title":"Transl Oncol"},{"key":"R84-20260904","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.2147\/CMAR.S270200","article-title":"Adipose mesenchymal stem cell-derived exosomal microRNA-1236 reduces resistance of breast cancer cells to cisplatin by suppressing SLC9A1 and the Wnt\/\u03b2-catenin signaling.","volume":"12","author":"Jia","year":"2020","journal-title":"Cancer Manag Res"},{"key":"R85-20260904","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3390\/biomedicines9070827","article-title":"Emerging evidence of the functional impact of the miR379\/miR656 cluster (C14MC) in breast cancer.","volume":"9","author":"McCarthy","year":"2021","journal-title":"Biomedicines"},{"key":"R86-20260904","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1038\/s41388-017-0116-9","article-title":"Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379.","volume":"37","author":"O\u2019Brien","year":"2018","journal-title":"Oncogene"},{"key":"R87-20260904","doi-asserted-by":"crossref","first-page":"5516078","DOI":"10.1155\/2021\/5516078","article-title":"Exosomes of mesenchymal stem cells as a proper vehicle for transfecting miR-145 into the breast cancer cell line and its effect on metastasis.","volume":"2021","author":"Sheykhhasan","year":"2021","journal-title":"Biomed Res Int"},{"key":"R88-20260904","doi-asserted-by":"crossref","first-page":"110341","DOI":"10.1016\/j.ygeno.2022.110341","article-title":"Bone marrow mesenchymal stem cells-derived exosomal microRNA-16-5p restrains epithelial-mesenchymal transition in breast cancer cells via EPHA1\/NF-\u03baB signaling axis.","volume":"114","author":"Zhang","year":"2022","journal-title":"Genomics"},{"key":"R89-20260904","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s13258-021-01200-1","article-title":"Mesenchymal stem cell-derived exosome mir-342-3p inhibits metastasis and chemo-resistance of breast cancer through regulating ID4.","volume":"44","author":"Yu","year":"2022","journal-title":"Genes Genomics"},{"key":"R90-20260904","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3390\/ijms22020844","article-title":"Delivery of miR-424-5p via extracellular vesicles promotes the apoptosis of MDA-MB-231 TNBC cells in the tumor microenvironment.","volume":"22","author":"Zhou","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R91-20260904","doi-asserted-by":"crossref","first-page":"120015","DOI":"10.1016\/j.lfs.2021.120015","article-title":"Evaluating the influence of human umbilical cord mesenchymal stem cells-derived exosomes loaded with miR-3182 on metastatic performance of triple negative breast cancer cells.","volume":"286","author":"Khazaei-Poul","year":"2021","journal-title":"Life Sci"},{"key":"R92-20260904","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1158\/0008-5472.CAN-16-1092","article-title":"Mesenchymal stem cell-derived exosomes stimulate cycling quiescence and early breast cancer dormancy in bone marrow.","volume":"76","author":"Bliss","year":"2016","journal-title":"Cancer Res"},{"key":"R93-20260904","doi-asserted-by":"crossref","first-page":"ra63","DOI":"10.1126\/scisignal.2005231","article-title":"Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells.","volume":"7","author":"Ono","year":"2014","journal-title":"Sci Signaling"},{"key":"R94-20260904","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s12015-019-09944-w","article-title":"Delivery of LNA-antimiR-142-3p by mesenchymal stem cells-derived exosomes to breast cancer stem cells reduces tumorigenicity.","volume":"16","author":"Naseri","year":"2020","journal-title":"Stem Cell Rev Rep"},{"key":"R95-20260904","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12943-018-0867-0","article-title":"Exosomes derived from mesenchymal stem cells enhance radiotherapy-induced cell death in tumor and metastatic tumor foci.","volume":"17","author":"de Araujo Farias","year":"2018","journal-title":"Mol Cancer"},{"key":"R96-20260904","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3390\/cancers11060798","article-title":"Taxol-loaded MSC-derived exosomes provide a therapeutic vehicle to target metastatic breast cancer and other carcinoma cells.","volume":"11","author":"Melzer","year":"2019","journal-title":"Cancers"},{"key":"R97-20260904","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.2147\/IJN.S210731","article-title":"Targeted delivery of doxorubicin to HER2 positive tumor models.","volume":"14","author":"Gomari","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"R98-20260904","doi-asserted-by":"crossref","first-page":"8347","DOI":"10.3390\/ijms21218347","article-title":"Anti-tumor effects of exosomes derived from drug-incubated permanently growing human MSC.","volume":"21","author":"Melzer","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R99-20260904","doi-asserted-by":"crossref","first-page":"1265291","DOI":"10.1080\/20013078.2017.1265291","article-title":"TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy.","volume":"6","author":"Yuan","year":"2017","journal-title":"J Extracell Vesicles"},{"key":"R100-20260904","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3389\/fonc.2020.01453","article-title":"The antitumor effect of gene-engineered exosomes in the treatment of brain metastasis of breast cancer.","volume":"10","author":"Liu","year":"2020","journal-title":"Front Oncol"},{"key":"R101-20260904","doi-asserted-by":"crossref","first-page":"118218","DOI":"10.1016\/j.lfs.2020.118218","article-title":"Adipose derived mesenchymal stem cell exosomes loaded with miR-10a promote the differentiation of Th17 and Treg from naive CD4(+) T cell.","volume":"259","author":"Bolandi","year":"2020","journal-title":"Life Sci"},{"key":"R102-20260904","doi-asserted-by":"crossref","first-page":"13974","DOI":"10.3390\/ijms232213974","article-title":"Harnessing normal and engineered mesenchymal stem cells derived exosomes for cancer therapy: opportunity and challenges.","volume":"23","author":"Ahmadi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R103-20260904","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1089\/scd.2013.0249","article-title":"Mesenchymal stem cells directly interact with breast cancer cells and promote tumor cell growth in vitro and in vivo.","volume":"22","author":"Mandel","year":"2013","journal-title":"Stem Cells Dev"},{"key":"R104-20260904","doi-asserted-by":"crossref","first-page":"e69658","DOI":"10.1371\/journal.pone.0069658","article-title":"In vivo fluorescence imaging reveals the promotion of mammary tumorigenesis by mesenchymal stromal cells.","volume":"8","author":"Ke","year":"2013","journal-title":"PLoS One"},{"key":"R105-20260904","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PRS.0000000000001321","article-title":"Human adipose-derived mesenchymal stromal cells may promote breast cancer progression and metastatic spread.","volume":"136","author":"Kamat","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"R106-20260904","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1186\/bcr3569","article-title":"Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways.","volume":"15","author":"Strong","year":"2013","journal-title":"Breast Cancer Res"},{"key":"R107-20260904","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/cbin.10198","article-title":"Characteristics of human adipose mesenchymal stem cells isolated from healthy and cancer affected people and their interactions with human breast cancer cell line MCF-7 in vitro.","volume":"38","author":"Trivanovi\u0107","year":"2014","journal-title":"Cell Biol Int"},{"key":"R108-20260904","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4161\/cbt.20561","article-title":"Mesenchymal stem cells in mammary adipose tissue stimulate progression of breast cancer resembling the basal-type.","volume":"13","author":"Zhao","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"R109-20260904","doi-asserted-by":"crossref","first-page":"e89595","DOI":"10.1371\/journal.pone.0089595","article-title":"Human adipose tissue-derived stromal\/stem cells promote migration and early metastasis of triple negative breast cancer xenografts.","volume":"9","author":"Rowan","year":"2014","journal-title":"PLoS One"},{"key":"R110-20260904","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/PRS.0b013e31829fe5b1","article-title":"Prevalence of endogenous CD34+ adipose stem cells predicts human fat graft retention in a xenograft model.","volume":"132","author":"Philips","year":"2013","journal-title":"Plast Reconstr Surg"},{"key":"R111-20260904","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11914-019-00532-y","article-title":"Breast cancer dormancy in bone.","volume":"17","author":"Clements","year":"2019","journal-title":"Curr Osteoporos Rep"},{"key":"R112-20260904","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canlet.2009.04.013","article-title":"Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion.","volume":"284","author":"Pinilla","year":"2009","journal-title":"Cancer Lett"},{"key":"R113-20260904","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11010-013-1746-z","article-title":"Exosomes from human adipose-derived mesenchymal stem cells promote migration through Wnt signaling pathway in a breast cancer cell model.","volume":"383","author":"Lin","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"R114-20260904","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis.","volume":"449","author":"Karnoub","year":"2007","journal-title":"Nature"},{"key":"R115-20260904","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.stem.2012.08.013","article-title":"CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNF\u03b1.","volume":"11","author":"Ren","year":"2012","journal-title":"Cell Stem Cell"},{"key":"R116-20260904","doi-asserted-by":"crossref","first-page":"30731","DOI":"10.1074\/jbc.M110.128124","article-title":"TNF\u03b1-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines.","volume":"285","author":"Shin","year":"2010","journal-title":"J Biol Chem"},{"key":"R117-20260904","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1290\/1071-2690(2000)036<0077:DOMFHB>2.0.CO;2","article-title":"Development of myofibroblasts from human bone marrow mesenchymal stem cells cocultured with human colon carcinoma cells and TGF beta 1.","volume":"36","author":"Emura","year":"2000","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"R118-20260904","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.4049\/jimmunol.1900692","article-title":"Exosomes produced by mesenchymal stem cells drive differentiation of myeloid cells into immunosuppressive M2-polarized macrophages in breast cancer.","volume":"203","author":"Biswas","year":"2019","journal-title":"J Immunol"},{"key":"R119-20260904","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1038\/srep02298","article-title":"Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice.","volume":"3","author":"Ljujic","year":"2013","journal-title":"Sci Rep"},{"key":"R120-20260904","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3727\/096368912X657954","article-title":"Hypoxia-induced secretion of TGF-\u03b21 in mesenchymal stem cell promotes breast cancer cell progression.","volume":"22","author":"Hung","year":"2013","journal-title":"Cell Transplant"},{"key":"R121-20260904","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ijc.23939","article-title":"Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells.","volume":"124","author":"Molloy","year":"2009","journal-title":"Int J Cancer"},{"key":"R122-20260904","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13287-019-1220-2","article-title":"Exosomes secreted by mesenchymal stromal\/stem cell-derived adipocytes promote breast cancer cell growth via activation of Hippo signaling pathway.","volume":"10","author":"Wang","year":"2019","journal-title":"Stem Cell Res Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048829","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:01:32Z","timestamp":1788530492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":122,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048829","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"2024-05-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}